Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Allovectin-7: Phase II trial update

Vical Inc. (VICL), San Diego, Calif.
Product: Allovectin-7
Business: Cancer
Therapeutic

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE